https://scholars.lib.ntu.edu.tw/handle/123456789/190518
標題: | Integrin alpha(v)beta(3)-Targeted Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using a Gadolinium-Loaded Polyethylene Gycol-Dendrimer-Cyclic RGD Conjugate to Evaluate Tumor Angiogenesis and to Assess Early Antiangiogenic Treatment Response in a Mouse Xenograft Tumor Model | 作者: | Chen, Wei-Tsung Shih, Tiffany Ting Fang Chen, Ran-Chou Tu, Shin-Yang Wen-Yuen, Hsieh Yang, Pang-Chyr |
公開日期: | 2012 | 卷: | 11 | 期: | 4 | 起(迄)頁: | 286-300 | 來源出版物: | Mol. Imaging | 摘要: | The purpose of this study was to validate an integrin alpha(v)beta(3)-targeted magnetic resonance contrast agent, PEG-G3-(Gd-DTPA)(6)-(cRGD-DTPA)(2), for its ability to detect tumor angiogenesis and assess early response to antiangiogenic therapy using dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI). Integrin alpha(v)beta(3)-positive U87 cells and control groups were incubated with fluorescein-labeled cRGD-conjugated dendrimer, and the cellular attachment of the dendrimer was observed. DCE MRI was performed on mice bearing KB xenograft tumors using either PEG-G3-(Gd-DTPA)(6)-(cRGD-DTPA)(2) or PEG-G3-(Gd-DTPA)(6)-(cRAD-DTPA)(2). DCE MRI was also performed 2 hours after anti-integrin alpha(v)beta(3) monoclonal antibody treatment and after bevacizumab treatment on days 3 and 6t. Using DCE MRI, the 30-minute contrast washout percentage was significantly lower in the cRGD-conjugate injection groups. The enhancement patterns were different between the two contrast injection groups. In the antiangiogenic therapy groups, a rapid increase in 30-minute contrast washout percentage was observed in both the LM609 and bevacizumab treatment groups, and this occurred before there was an observable decrease in tumor size. The integrin alpha(v)beta(3) targeting ability of PEG-G3-(Gd-DTPA)(6)-(cRGD-DTPA)(2) in vitro and in vivo was demonstrated. The 30-minute contrast washout percentage is a useful parameter for examining tumor angiogenesis and for the early assessment of antiangiogenic treatment response. |
URI: | http://ntur.lib.ntu.edu.tw//handle/246246/259402 |
顯示於: | 醫學系 |
檔案 | 描述 | 大小 | 格式 | |
---|---|---|---|---|
index.html | 23.17 kB | HTML | 檢視/開啟 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。